According to reports, Pfizer is claiming that early analysis of their COVID-19 vaccine is 90% effective.
"An error during routine maintenance last Friday resulted in a county data vendor sending erroneous texts and email messages to people saying they were positive for COVID-19", the statement on the county website said.
Trump, who had suggested during the presidential campaign that a vaccine could be ready by Election Day, tweeted on Monday: "STOCK MARKET UP BIG, VACCINE COMING SOON". Pfizer and BioNTech estimate two months of safety data following the second (final) dose needs to be procured before results can be confirmed. He ticked off many questions still to be answered, including how long the vaccine's effects last and whether it protects older people as well as younger ones.
Dr Bourla said: "The first set of results from our Phase three Covid-19 vaccine trial provides the initial evidence of our vaccine's ability to prevent Covid-19".
To this, the answer as of now is a simple NO.
Stock markets rocketed higher Monday after Pfizer said early data show its coronavirus vaccine is effective and investors breathed a sigh of relief after days of USA presidential limbo ended with Democrat Joe Biden declared the president-elect.
The UK has secured 40 million doses in total of the vaccine.
The placebo group is one in which people are given a fake vaccine so that what happens to them can be compared with those who get the real thing.
Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, called the trial results "extraordinary" and said Pfizer's success bodes well for a similar vaccine being developed by US firm Moderna.
However, the spokesperson added, they're not certain: "We are moving at the speed of science".
"We were never part of the Warp Speed", Kathrin Jansen, a senior vice president and the head of vaccine research and development at Pfizer told the New York Times.
"SUCH GREAT NEWS!" the President tweeted minutes after Pfizer announced the development and days after he lost the United States presidential election to Democrat Joe Biden.
No participant so far has become severely ill, Gruber said. Democratic Connecticut Sen. Chris Murphy - a regular, vocal critic of Trump - noted that while the outgoing president shouldn't take credit for the vaccine, this was a public-private partnership. The vaccine appears to be 90 percent effective, and there have been no safety concerns.
Andrew Cuomo, who has somehow become an authority among liberals on how to properly manage the response to COVID-19 in spite of his state's objectively awful coronavirus outcomes, said on "Good Morning America" on Monday that it is "bad news" that the potential COVID-19 vaccine was developed "two months before Joe Biden takes over" and promised that he would do whatever he could to stop the Trump administration's rollout of the vaccine.
Biden has vowed to move decisively to try to counter the worsening coronavirus pandemic, which has sapped economic growth, trade and travel, as the US and Europe face a troubling rise in infections.
The so-called messenger RNA, or mRNA, vaccine is a new approach to protecting against viral infection.